| Product NDC: | 52544-044 |
| Proprietary Name: | Cordran |
| Non Proprietary Name: | Flurandrenolide |
| Active Ingredient(s): | 4 ug/cm2 & nbsp; Flurandrenolide |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | TAPE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 52544-044 |
| Labeler Name: | Watson Pharma, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA016455 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19690729 |
| Package NDC: | 52544-044-24 |
| Package Description: | 450 cm2 in 1 CARTON (52544-044-24) |
| NDC Code | 52544-044-24 |
| Proprietary Name | Cordran |
| Package Description | 450 cm2 in 1 CARTON (52544-044-24) |
| Product NDC | 52544-044 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Flurandrenolide |
| Dosage Form Name | TAPE |
| Route Name | TOPICAL |
| Start Marketing Date | 19690729 |
| Marketing Category Name | NDA |
| Labeler Name | Watson Pharma, Inc. |
| Substance Name | FLURANDRENOLIDE |
| Strength Number | 4 |
| Strength Unit | ug/cm2 |
| Pharmaceutical Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |